Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

124.27 +2.44 (+2.00%)

Streaming Delayed Price Updated: 3:03 PM EDT, Mar 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Recession Fears are Creating a Golden Opportunity for Biotech Stocks ↗

April 08, 2022

Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.

Via InvestorPlace

Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks ↗

April 08, 2022

Cash will be king in biotech picks like BLUE stock as governments slow approvals and reimbursements of new gene therapies.

Via InvestorPlace

The “Shake It Off” Stock Market (And Sentiment Results) ↗

April 07, 2022

We may be close to a short term peak in yields – bottom in bonds

Via Talk Markets

Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results ↗

April 05, 2022

SBFM stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells.

Via InvestorPlace

Good Entry Point for Biotech Stocks ↗

April 04, 2022

Life science and biotech stocks had a good week with the most well-known ETFs up 3-4% for the week and off recent bottoms.

Via Talk Markets

XBI Biotech 15% Potential ↗

February 08, 2022

The Biotech Sector ETF had a very nice rally, a bull flag, and ended up having the second half of the move to the upside.

Via Talk Markets

Top 10 Investment Themes For 2022 ↗

December 25, 2021

What are the investment trends going to look like for 2022?

Via Talk Markets

ETF Battles: Which Biotech Stock ETF Is The Better Choice? - It's IBB Vs. XBI ↗

December 23, 2021

A biotech clash between the iShares Biotechnology ETF and the SPDR S&P Biotech ETF.

Via Talk Markets

CNBC's Final Call: Newmont, Biotech ETF And This Energy Stock ↗

April 04, 2022

On CNBC's "The Final Call," Carter Worth recommended Newmont Corporation (NYSE: NEM). The stock has jumped almost 36% year to date.

Via Benzinga

Acadia: Helping With Alzheimers And Parkinsons ↗

April 03, 2022

Things always change fast in biotech, but until recently things have been moving consistently to the downside. It’s been a while, but we believe this is finally over. And we believe Acadia...

Via Talk Markets

Biotech Funds and ETFs Continue to Lag ↗

March 28, 2022

It’s no secret that market sectors driving inflation are leading the market. With the US economy still strong and the War in Ukraine limiting supply of nat gas and raw materials, producer costs are...

Via Talk Markets

How do Biotechnology Funds and ETFs Perform Over Five Years? ↗

March 21, 2022

Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV.

Via Talk Markets

AskSlim Market Week - Friday, March 18 ↗

March 18, 2022

Technical and cycle analysis, and market commentary.

Via Talk Markets

3 Market ETF Stocks to Buy This Week on Fed Jitters ↗

March 14, 2022

The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over.

Via InvestorPlace

Tough Slogging Ahead for Investors, Diversification is Important ↗

March 07, 2022

Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.

Via Talk Markets

3 Moonshot Stocks Insiders Are Buying. What Do They Know? ↗

February 25, 2022

Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature.

Via InvestorPlace

3 Desirable Drug Stocks With Very Promising Pipelines ↗

February 16, 2022

Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.

Via InvestorPlace

Large Cap Biopharma- Well Positioned For Choppy Markets ↗

February 14, 2022

If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.

Via Talk Markets

The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)… ↗

February 11, 2022

China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing.

Via Talk Markets

Small Cap Biotech Stocks: Is it time to start trading? ↗

January 31, 2022

It’s time to trade beaten-up small cap biotech stocks.

Via Talk Markets

3 Pharma Stocks Yielding Over 3% ↗

January 18, 2022

The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.

Via Talk Markets

9 Monster Stock Market Predictions – The Week Of Jan. 17 ↗

January 17, 2022

The chart for the SPX is looking more and more like a diamond pattern.

Via Talk Markets

3 Biotech Stocks to Buy That Are Under Severe Pressure ↗

January 13, 2022

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

Via InvestorPlace

Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗

January 10, 2022

Pfizer and Bayer inked deals with several companies in gene-editing.

Via Investor's Business Daily

Whitney Tilson Names Cannabis ETF 'Favorite Pick For 2022' But Clock Is Ticking To Change US Regulations ↗

January 03, 2022

It was another brutal year for cannabis stock investors in 2021 as the U.S. made very little regulatory progress on cannabis reform measures. Fortu...

Via Benzinga

Fear & Greed In The Biotech Sector ↗

January 02, 2022

With rates rising, widespread tax-loss selling, and fund manager’s either closing the books for 2021 or just closing down altogether, the market has entered a major risk off phase and biotech stocks...

Via Talk Markets

Healthcare Stocks Are Winners And Provide Diversification To Your Portfolio ↗

December 30, 2021

As we have written their year many times speculative small cap biotechs have not done well in 2021 since they peaked in February.

Via Talk Markets

The Bear Market Is Already Here – But Not For Dividend Investors ↗

December 22, 2021

While the broad stock market indices remain at near-record levels, there are sectors of the market that have dropped into correction or even bear market territory over recent months.

Via Talk Markets

Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot ↗

December 22, 2021

The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.

Via Talk Markets

10 Bargain Stocks to Buy After Falling 30% in 2021 ↗

December 20, 2021

If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.